Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: Efficacy and safety results of the zometa european study (ZEUS)

1. Wirth, M.
2. Tammela, T.
3. Cicalese, V.
4. Gomez Veiga, F.
5. Delaere, K.
6. Miller, K.
7. Tubaro, A.
8. Schulze, M.
9. Debruyne, F.
10. Huland, H.
11. Patel, A.
12. Lecouvet, F.
13. Caris, C.
14. Witjes, W.